This study showed that KRAS mutation was observed in 47.4% of the 38 resected patients with hilar cholangiocarcinoma and in 22.2% of the 18 resected patients with intrahepatic cholangiocarcinoma invading the hilum. The gene discussed is KRAS; the disease is intrahepatic cholangiocarcinoma.